[{"NetIncomeLoss_1_Q1_USD":-72593000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":15821000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":67082161.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q1_USD":-1.08,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":7536000.0,"ContractWithCustomerAssetNetCurrent_0_Q1_USD":5235000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q1_USD":538000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-2000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"DepreciationAndAmortization_1_Q1_USD":800000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":62826000.0,"WeightedAverageNumberOfSharesIssuedBasic_1_Q1_shares":68476799.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q1_USD":0.0,"AssetsCurrent_0_Q1_USD":841870000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q1_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":14706123.0,"AvailableForSaleSecurities_0_Q1_USD":884912000.0,"CommonStockSharesIssued_0_Q1_shares":70965513.0,"Assets_0_Q1_USD":935119000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-46000.0,"PaymentsToAcquireInvestments_1_Q1_USD":192398000.0,"DeferredRevenueRevenueRecognized1_1_Q1_USD":9461000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q1_USD":884914000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":-63000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":66387000.0,"CommonStockValue_0_Q1_USD":7000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":57986000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":58000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":222120000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"AvailableForSaleSecuritiesCurrent_0_Q1_USD":436666000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q1_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-72639000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":7722000.0,"OtherAssetsNoncurrent_0_Q1_USD":6183000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":390260000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":14706000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_1_Q1_USD":251365000.0,"Liabilities_0_Q1_USD":270329000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":1885000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":-2007000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":-2000.0,"RevenueFromRelatedParties_1_Q1_USD":7711000.0,"ShareBasedCompensation_1_Q1_USD":12761000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-9461000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":12243000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-400777000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":218630000.0,"CommonStockSharesOutstanding_0_Q1_shares":70965513.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"RestrictedCashNoncurrent_0_Q1_USD":1988000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-46000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":12761000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-66316000.0,"LiabilitiesCurrent_0_Q1_USD":132055000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q1_USD":4924000.0,"AccountsPayableCurrent_0_Q1_USD":24544000.0,"IncreaseDecreaseInContractWithCustomerAsset_1_Q1_USD":4186000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":8680000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":390260000.0,"AdditionalPaidInCapital_0_Q1_USD":1065562000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":392248000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q1_USD":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":2784000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":14849000.0,"NonoperatingIncomeExpense_1_Q1_USD":154000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-506000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":3641000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":113369000.0,"InterestReceivableCurrent_0_Q1_USD":1029000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":4568000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"CommonStockSharesAuthorized_0_Q1_shares":400000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":9461000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q1_shares":1394638.0,"OperatingIncomeLoss_1_Q1_USD":-72747000.0,"AvailableForSaleSecuritiesNoncurrent_0_Q1_USD":57986000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":56000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":74571000.0,"PreferredStockValue_0_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":935119000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":7128000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":12761000.0,"OperatingExpenses_1_Q1_USD":82208000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.08,"ProfitLoss_1_Q1_USD":-72593000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":10199000.0,"OtherLiabilitiesCurrent_0_Q1_USD":2381000.0,"StockholdersEquity_0_Q1_USD":664790000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"AccruedProfessionalFeesCurrent_0_Q1_USD":67000.0,"Ticker":"RCUS","CIK":"1724521","name":"ARCUS BIOSCIENCES, INC.","OfficialName":"Arcus Biosciences Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2226368293.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210505"}]